This study quantifies changes in neuro-oncological care during the height of the pandemic and investigates patient outcomes in 2020 compared to a historical control.
The Innovative Health Initiative (IHI) has just published draft topic texts for its upcoming Call 11, expected to launch officially in late June 2025.
Latest Posts
-
-
Breaking newsCOVID-19The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic
In this article the authors aimed to investigate the frequency and clinical associations of COVID-19 vaccine-related headache. -
Breaking newsCOVID-19
Long-term neurological manifestations of COVID-19: prevalence and predictive factors
From a sample of 208 consecutive non-neurological patients hospitalised for COVID-19 disease, 165 survivors were re-assessed at 6 months according to a structured standardised clinical protocol. -
Breaking newsCOVID-19Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies
The objective of this study was to estimate whether the risk of death from COVID-19 in patients with multiple sclerosis (MS) exceeds that of the general population. -
Breaking newsCOVID-19
Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
In this article the authors reviewed all vaccine related CVT published cases by April 30, 2021. -
Breaking newsCOVID-19
Central neuroinflammation in COVID-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies
This study aims to determine the profile and possible mechanisms behind CNS inflammatory diseases in the context of COVID-19. -
Breaking newsCOVID-19
COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection
This bi-center longitudinal study evaluated symptoms in consecutive COVID-19 patients in the participating practices. -
Breaking newsCOVID-19
Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic
In this article the authors provide an overview on BTKi mechanisms relevant to COVID-19 infection and vaccination and review preliminary data on BTKi use in patients with COVID-19. -
Breaking newsCOVID-19
Risk of thrombocytopenia and thromboembolism after COVID-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
This Self-controlled case series study using national data on COVID-19 vaccination and hospital admissions. -
In this study the authors investigated the effect of vaccination of health care workers in Scotland on the risk of coronavirus disease 2019 (COVID-19) among members of their households.
-
In this ongoing trial, the authors randomly assigned 44,165 participants aged 16 or older and 2,264 participants aged 12-15 to receive two 30-μg doses, at 21 days apart, of BNT162b2 or placebo. -
EAN was able to welcome 46 participants from 15 countries - Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Poland, Portugal, Romania, Russia, Spain, Tunisia, Turkey and Ukraine - to Loutraki. -
Breaking newsCOVID-19
Clinical perception and management of Parkinson’s disease during the COVID-19 pandemic: A Canadian experience
The objective of this study was to explore the perceived impact of confinement in patients with Parkinson's disease and document the effects of gender and living environment. -
Breaking newsCOVID-19
Association Between Psychological Distress, Cognitive Complaints, and Neuropsychological Status After a Severe COVID-19 Episode: A Cross-Sectional Study
This study aimed to explore the associations of objective cognitive performances and psychological distress with cognitive complaints in COVID-19 survivors. -
Breaking newsCOVID-19
Characteristics and Outcomes of Parkinson’s Disease Individuals Hospitalized with COVID-19 in a New York City Hospital System
The objective of this study was to determine clinical characteristics and outcomes in hospitalised PD individuals infected with COVID-19.